Results 111 to 120 of about 9,143 (202)
Reviews in Medical Virology, Volume 36, Issue 4, July 2026.ABSTRACT Human papillomavirus (HPV) is the most common sexually transmitted infection worldwide and is responsible for anogenital warts and several cancers. Although the effectiveness of female HPV vaccination has been well established since its introduction in 2006, no systematic review has specifically evaluated the impact of male vaccination ...
Anna Beltrame +5 more
wiley +1 more source
Generation and production of AAVLP(HPV16/31L2).
, 2013 A) Schematic presentation of the chimeric VP3 protein with the insertions of the HPV31 and HPV16 L2 peptides. The amino acid residues refer to the VP1 protein sequence. Solid lines indicate the VP3 protein and open bars the L2 peptides.
Uwe Michaelis (318085) +13 more
core +1 more source
International Journal of Cancer, Volume 158, Issue 12, Page 3141-3151, 15 June 2026.What's new? Persistent infection with high‐risk human papillomavirus (HPV) causes most invasive cervical cancer cases, leading many countries to transition from cytology to primary HPV‐based screening. Despite the benefits, HPV‐based screening may also lead to unnecessary procedures, psychological burden, and strain on healthcare systems.
Kelsi R. Kroon +2 more
wiley +1 more source
BMC Medical GenomicsBackground There is a high incidence of cervical cancer in Xinjiang. Genetic variation in human papillomavirus may increase its ability to invade, spread, and escape host immune response.
Haozheng Cheng +9 more
doaj +1 more source
Internalization of exosomes into DonorI-HPV16 HFKs.
, 2017 (A) DonorI-HPV16 HFKs were incubated with exosomes labelled with fluorescent dye PKH67 in 10, 20 and 40 μL of exosome suspension and observed for PKH67 positive cells at 6 and 24 hours post incubation.
Tipaya Ekalaksananan (533007) +8 more
core +1 more source
International Journal of Cancer, Volume 158, Issue 12, Page 3197-3207, 15 June 2026.What's new? Primary human papillomavirus (HPV)–based screening has shown superiority to cytology‐based screening in reducing cervical cancer risk in clinical trials. However, the benefit must be balanced with potential overdiagnosis/overtreatment.
Jeppe Bennekou Schroll +11 more
wiley +1 more source
Immunoresponse of AAVLP(HPV16/31L2) in rabbits.
, 2013 Three rabbits were immunized i.m. four times with AAVLP(HPV16/31L2) particles (2E+12 capsids equivalent to 13.2 µg) together with montanide ISA720 as an adjuvant. A) Ten weeks after the first immunization sera was analyzed by an L2 peptide-based ELISA to
Uwe Michaelis (318085) +13 more
core +1 more source
Targeted modulation of IGFL2‐AS1 reveals its translational potential in cervical adenocarcinoma
Molecular Oncology, Volume 20, Issue 6, Page 1643-1660, June 2026.Cervical adenocarcinoma patients face worse outcomes than squamous cell carcinoma counterparts despite similar treatment. The identification of IGFL2‐AS1's differential expression provides a molecular basis for distinguishing these histotypes, paving the way for personalized therapies and improved survival in vulnerable populations globally.
Ricardo Cesar Cintra +6 more
wiley +1 more source
Frequency distribution of HPV16 3′-breakpoints in different segments of the HPV16 early region.
, 2013 The distribution of HPV16 3′-breakpoints of viral-cellular DNA junctions (n = 74) was analyzed within the five different segments E1, E2, E5, E1-Ac and Ac-PAE of the HPV16 early region.
Elisabeth Schwarz (83829) +6 more
core +1 more source